Taiwanese drug in Macau found to contain plasticizer
June 2, 2011, 10:46 pm TWN
TAIPEI--The Food and Drug Administration (FDA) confirmed Wednesday that a Taiwanese-made prescription drug sold in Macau has been found to contain a banned plasticizer.
The antacid drug Scrat Suspension was tested positive for DIBP by the Macau health authorities, who later issued a notice of recall to local importers and pharmacies.
FDA official Hsu Chien-wen said in a telephone interview that the product was tested free of six types of plasticizers — DEHP, DINP, DNOP, DIDP, DBP, and BBP — before being shipped to Macau.
DIBP, however, was not tested for.
Hsu further noted that all the ingredients used by Standard Chem. and Pharm. Co. to produce the drug were imported from overseas, with the exception of ethanol, which was produced in Taiwan.
Wu San-fa, a spokesman for Standard Chem. & Pharm. Co., said that the news appeared “strange” because clouding agents and plasticizers are not on the list of ingredients.
He said the presence of plasticizer might have come from the product's outer packaging.
Although the company has not seen the test results obtained by the Macau government and is not sure of the amount of plasticizer residue, it has nevertheless notified its retailers to pull the product off the shelves in Taiwan and Macau.
Local consumers can obtain refunds at the point of purchase, he went on, noting that the product was manufactured mainly for export to Macau and Vietnam.